Trends In Nanomedicines For Cancer Treatment.
CONCLUSION: The combination of drugs in nanosystems helps to increase efficacy and decrease toxicity. Based on the results found, nanoparticles and liposomes are the most commonly used nanocarriers for drug encapsulation. In addition, although few nanomedicines are commercially available, the research area is continuously growing.
PMID: 32186271 [PubMed - as supplied by publisher]
Source: Current Pharmaceutical Design - Category: Drugs & Pharmacology Authors: do Nascimento T, Todeschini AR, Santos-Oliveira R, de Bustamante Monteiro MSS, de Souza VT, Ricci-JĂșnior E Tags: Curr Pharm Des Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Therapy | Databases & Libraries | Drugs & Pharmacology | Gene Therapy | Genetics | Nanotechnology | Science | Study | Toxicology